AIGP · Question #81
CASE STUDY Please use the following to answer the next question: A mid-size US healthcare network has decided to develop an AI solution to detect a type of cancer that is most likely to arise in adult
The correct answer is D. Review the terms of use.. Reviewing the terms of use is essential to ensure legal compliance and appropriate permissions when gathering data from the clinical research partner during the design phase.
Question
CASE STUDY Please use the following to answer the next question:
A mid-size US healthcare network has decided to develop an AI solution to detect a type of cancer that is most likely to arise in adults. Specifically, the healthcare network intends to create a recognition algorithm that will perform an initial review of all imaging and then route records to a radiologist for secondary review pursuant to agreed-upon criteria (e.g., a confidence score below a threshold). To date, the healthcare network has:
- Defined its AI ethical principles.
- Conducted discovery to identify the intended uses and success
criteria for the system.
- Established an AI risk committee.
- Assembled a cross-functional team with clear roles and
responsibilities.
- Created policies and procedures to document standards, workflows,
timelines and risk thresholds during the project. The healthcare network intends to retain a cloud provider to host the solution. It also intends to retain a large consulting firm to supplement its small data science team and help develop the algorithm using the healthcare network’s existing data and de-identified data that is licensed from a large US clinical research partner. In the design phase, which of the following steps is most important in gathering the data from the clinical research partner?
Options
- APerform a privacy impact assessment.
- BCombine only anonymized data.
- CSegregate the data sets.
- DReview the terms of use.
How the community answered
(39 responses)- A5% (2)
- B3% (1)
- C8% (3)
- D85% (33)
Explanation
Reviewing the terms of use is essential to ensure legal compliance and appropriate permissions when gathering data from the clinical research partner during the design phase.
Topics
Community Discussion
No community discussion yet for this question.